Panagora Asset Management Inc Nevro Corp Transaction History

Panagora Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$13.56 - $20.78 $565,845 - $867,128	-41,729 Reduced 53.22%	36,675 $529,000
Q4 2023 Feb 08, 2024	BUY	$14.18 - $22.31 $6,366 - $10,017	449 Added 0.58%	78,404 $1.69 Million
Q3 2023 Oct 31, 2023	BUY	$18.22 - $25.85 $535,904 - $760,326	29,413 Added 60.59%	77,955 $1.5 Million
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $1.1 Million - $1.91 Million	48,542 New	48,542 $1.23 Million
Q1 2021 May 12, 2021	SELL	$132.81 - $182.18 $717,705 - $984,500	-5,404 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$138.17 - $184.34 $746,670 - $996,173	5,404 New	5,404 $935,000
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $1.19 Million - $1.51 Million	-10,410 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$89.45 - $129.85 $523,819 - $760,401	-5,856 Reduced 36.0%	10,410 $1.24 Million
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $1,123 - $2,308	-16 Reduced 0.1%	16,266 $1.63 Million
Q4 2019 Feb 12, 2020	BUY	$76.41 - $117.54 $450,666 - $693,250	5,898 Added 56.8%	16,282 $1.91 Million
Q3 2019 Nov 12, 2019	BUY	$61.52 - $91.1 $638,823 - $945,982	10,384 New	10,384 $893,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.